Antibiotics regulate the immune response in both presence and absence of lipopolysaccharide through modulation of Toll-like receptors, cytokine production and phagocytosis in vitro

Kumar, 2011, Nationwide trends of severe sepsis in the 21st century (2000–2007), Chest, 140, 1223, 10.1378/chest.11-0352 Rittirsch, 2008, Harmful molecular mechanisms in sepsis, Nat Rev Immunol, 8, 776, 10.1038/nri2402 Kumar, 2011, Pathogen recognition by the innate immune system, Int Rev Immunol, 30, 16, 10.3109/08830185.2010.529976 Kawai, 2010, The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors, Nat Immunol, 11, 373, 10.1038/ni.1863 van der, 2008, Host-pathogen interactions in sepsis, Lancet Infect Dis, 8, 32, 10.1016/S1473-3099(07)70265-7 Blander, 2004, Regulation of phagosome maturation by signals from Toll-like receptors, Science, 304, 1014, 10.1126/science.1096158 Roger, 2009, Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4, Proc Natl Acad Sci U S A, 106, 2348, 10.1073/pnas.0808146106 Williams, 2003, Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality, Crit Care Med, 31, 1808, 10.1097/01.CCM.0000069343.27691.F3 Weighardt, 2002, Cutting edge: myeloid differentiation factor 88 deficiency improves resistance against sepsis caused by polymicrobial infection, J Immunol, 169, 2823, 10.4049/jimmunol.169.6.2823 Pasquale, 2005, Nonantimicrobial effects of antibacterial agents, Clin Infect Dis, 40, 127, 10.1086/426545 Tauber, 2008, Immunomodulatory properties of antibiotics, Curr Mol Pharmacol, 1, 68, 10.2174/1874467210801010068 Purswani, 2002, Effect of ciprofloxacin on lethal and sublethal challenge with endotoxin and on early cytokine responses in a murine in vivo model, J Antimicrob Chemother, 50, 51, 10.1093/jac/dkf091 Shapira, 1996, Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion, Infect Immun, 64, 825, 10.1128/IAI.64.3.825-828.1996 Giamarellos-Bourboulis, 2004, Immunomodulatory clarithromycin treatment of experimental sepsis and acute pyelonephritis caused by multidrug-resistant Pseudomonas aeruginosa, Antimicrob Agents Chemother, 48, 93, 10.1128/AAC.48.1.93-99.2004 Ivetic, 2006, Anti-inflammatory activity of azithromycin attenuates the effects of lipopolysaccharide administration in mice, Eur J Pharmacol, 539, 131, 10.1016/j.ejphar.2006.03.074 Giamarellos-Bourboulis, 2008, Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia, Clin Infect Dis, 46, 1157, 10.1086/529439 Tsuchiya, 1980, Establishment and characterization of a human acute monocytic leukemia cell line (THP-1), Int J Cancer, 26, 171, 10.1002/ijc.2910260208 Tsugita, 2008, General anaesthesia and TrkA mRNA in peripheral blood mononuclear cells, Eur J Anaesthesiol, 25, 1032, 10.1017/S0265021508004766 Schefe, 2006, Quantitative real-time RT-PCR data analysis: current concepts and the novel “gene expression's CT difference” formula, J Mol Med, 84, 901, 10.1007/s00109-006-0097-6 Wan, 1993, A rapid and simple microfluorometric phagocytosis assay, J Immunol Methods, 162, 1, 10.1016/0022-1759(93)90400-2 Wiersinga, 2011, Current insights in sepsis: from pathogenesis to new treatment targets, Curr Opin Crit Care, 17, 480, 10.1097/MCC.0b013e32834a4aeb Tsujimoto, 2008, Role of Toll-like receptors in the development of sepsis, Shock, 29, 315, 10.1097/SHK.0b013e318157ee55 Milano, 1997, Intraperitoneal injection of tetracyclines protects mice from lethal endotoxemia downregulating inducible nitric oxide synthase in various organs and cytokine and nitrate secretion in blood, Antimicrob Agents Chemother, 41, 117, 10.1128/AAC.41.1.117 Yasutomi, 2005, Erythromycin differentially inhibits lipopolysaccharide- or poly(I:C)-induced but not peptidoglycan-induced activation of human monocyte-derived dendritic cells, J Immunol, 175, 8069, 10.4049/jimmunol.175.12.8069 Araujo, 2002, Effect of moxifloxacin on secretion of cytokines by human monocytes stimulated with lipopolysaccharide, Clin Microbiol Infect, 8, 26, 10.1046/j.1469-0691.2002.00374.x Petit, 1987, Influence of ciprofloxacin and piperacillin on interleukin-1 production by murine macrophages, J Antimicrob Chemother, 20, 615, 10.1093/jac/20.4.615 Zager, 2007, Gentamicin suppresses endotoxin-driven TNF-alpha production in human and mouse proximal tubule cells, Am J Physiol Renal Physiol, 293, F1373, 10.1152/ajprenal.00333.2007 Bailly, 1990, Quinolone-induced differential modification of IL-1 alpha and IL-1 beta production by LPS-stimulated human monocytes, Cell Immunol, 128, 277, 10.1016/0008-8749(90)90025-M Bailly, 1991, Ciprofloxacin treatment in vivo increases the ex vivo capacity of lipopolysaccharide-stimulated human monocytes to produce IL-1, IL-6 and tumour necrosis factor-alpha, Clin Exp Immunol, 85, 331, 10.1111/j.1365-2249.1991.tb05728.x Calvano, 2003, Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and Toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to tolerance, Shock, 20, 415, 10.1097/01.shk.0000092269.01859.44 Levy, 2004, Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848, J Immunol, 173, 4627, 10.4049/jimmunol.173.7.4627 Devaraj, 2005, Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-{alpha} and -{beta}, Diabetes, 54, 85, 10.2337/diabetes.54.1.85 Golub, 1991, Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs, Crit Rev Oral Biol Med, 2, 297, 10.1177/10454411910020030201 Webster, 1994, Inhibition of a model of in vitro granuloma formation by tetracyclines and ciprofloxacin. Involvement of protein kinase C, Arch Dermatol, 130, 748, 10.1001/archderm.1994.01690060078008 Loegering, 2011, Protein kinase C and Toll-like receptor signaling, Enzyme Res, 2011, 537821, 10.4061/2011/537821 Desaki, 2004, Molecular mechanisms of anti-inflammatory action of erythromycin in human bronchial epithelial cells: possible role in the signaling pathway that regulates nuclear factor-kappaB activation, Antimicrob Agents Chemother, 48, 1581, 10.1128/AAC.48.5.1581-1585.2004 Weiss, 2004, Anti-inflammatory effects of moxifloxacin on activated human monocytic cells: inhibition of NF-kappaB and mitogen-activated protein kinase activation and of synthesis of proinflammatory cytokines, Antimicrob Agents Chemother, 48, 1974, 10.1128/AAC.48.6.1974-1982.2004 Van, 2008, Contrasting effects of human THP-1 cell differentiation on levofloxacin and moxifloxacin intracellular accumulation and activity against Staphylococcus aureus and Listeria monocytogenes, J Antimicrob Chemother, 62, 518, 10.1093/jac/dkn232 Adinolfi, 1988, Enhanced phagocytosis, killing, and serum sensitivity of Escherichia coli and Staphylococcus aureus treated with sub-MICs of imipenem, Antimicrob Agents Chemother, 32, 1012, 10.1128/AAC.32.7.1012 Fitzgerald, 2000, Lipopolysaccharide induces scavenger receptor A expression in mouse macrophages: a divergent response relative to human THP-1 monocyte/macrophages, J Immunol, 164, 2692, 10.4049/jimmunol.164.5.2692 Iyori, 2008, Resveratrol modulates phagocytosis of bacteria through an NF-kappaB-dependent gene program, Antimicrob Agents Chemother, 52, 121, 10.1128/AAC.00210-07 Pechkovsky, 1996, Different patterns of cytokine regulation of phagocytosis and bacterial killing by human neutrophils, Int J Antimicrob Agents, 7, 33, 10.1016/0924-8579(96)00007-6 Jansen, 1992, Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass, Ann Thorac Surg, 54, 744, 10.1016/0003-4975(92)91021-Z Steinberg, 1993, Cytokine and complement levels in patients undergoing cardiopulmonary bypass, J Thorac Cardiovasc Surg, 106, 1008, 10.1016/S0022-5223(19)33971-6 Struber, 1999, Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass, Ann Thorac Surg, 68, 1330, 10.1016/S0003-4975(99)00729-8 Franke, 2005, Pro-inflammatory cytokines after different kinds of cardio-thoracic surgical procedures: is what we see what we know?, Eur J Cardiothorac Surg, 28, 569, 10.1016/j.ejcts.2005.07.007